We are live on ! Find out more
GVI

Green Valley Investors Portfolio holdings

AUM $1.76B
1-Year Est. Return 5.64%
This Fund
S&P 500
This Quarter Est. Return
-9.16%
1 Year Est. Return
+5.64%
3 Year Est. Return
+59.43%
5 Year Est. Return
+81.11%
10 Year Est. Return
AUM
$4.66B
AUM Growth
-$532M
Cap. Flow
-$41.4M
Cap. Flow %
-0.89%
Top 10 Hldgs %
66.13%
Holding
29
New
2
Increased
3
Reduced
2
Closed
2

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$174M
2
ABBV icon
AbbVie
ABBV
+$67.2M
3
SYY icon
Sysco
SYY
+$47.7M
4
HSIC icon
Henry Schein
HSIC
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 58.31%
2 Consumer Discretionary 13.19%
3 Materials 12.04%
4 Consumer Staples 7.88%
5 Communication Services 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESRX
1
DELISTED
Express Scripts Holding Company
ESRX
$733M 15.71%
9,050,000
CELG
2
DELISTED
Celgene Corp
CELG
$498M 10.67%
4,600,000
JNJ icon
3
Johnson & Johnson
JNJ
$641B
$338M 7.26%
3,625,000
GILD icon
4
Gilead Sciences
GILD
$166B
$295M 6.32%
3,000,000
LKQ icon
5
LKQ Corp
LKQ
$6.73B
$221M 4.74%
7,800,000
TJX icon
6
TJX Companies
TJX
$179B
$214M 4.59%
6,000,000
SYK icon
7
Stryker
SYK
$134B
$207M 4.44%
2,200,000
DIS icon
8
Walt Disney
DIS
$171B
$204M 4.38%
2,000,000
+300,000
+18% +$32.7M
WMT icon
9
Walmart Inc
WMT
$908B
$195M 4.17%
9,000,000
MAR icon
10
Marriott International
MAR
$100B
$180M 3.85%
2,634,371
TFCFA
11
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$162M 3.47%
6,000,000
+1,500,000
+33% +$44.8M
TMO icon
12
Thermo Fisher Scientific
TMO
$213B
$147M 3.15%
1,200,000
IFF icon
13
International Flavors & Fragrances
IFF
$20.2B
$145M 3.1%
1,400,000
BHC icon
14
Bausch Health
BHC
$1.68B
$143M 3.06%
800,000
PX
15
DELISTED
Praxair Inc
PX
$122M 2.62%
1,200,000
+200,000
+20% +$22.1M
ABT icon
16
Abbott
ABT
$189B
$121M 2.59%
3,000,000
AGN
17
DELISTED
Allergan plc
AGN
$109M 2.33%
+400,000
New +$123M
POT
18
DELISTED
Potash Corp Of Saskatchewan
POT
$108M 2.31%
5,250,000
PG icon
19
Procter & Gamble
PG
$337B
$99.3M 2.13%
1,380,000
HSIC icon
20
Henry Schein
HSIC
$9.78B
$78.3M 1.68%
1,505,367
-255,000
-14% -$14.1M
APD icon
21
Air Products & Chemicals
APD
$65.4B
$76.5M 1.64%
648,600
DD icon
22
DuPont de Nemours
DD
$18.7B
$67.8M 1.45%
631,810
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$124B
$52.1M 1.12%
500,000
CL icon
24
Colgate-Palmolive
CL
$74.5B
$44.4M 0.95%
700,000
MON
25
DELISTED
Monsanto Co
MON
$42.7M 0.91%
500,000

Similar funds

Green Valley Investors's Q3 2015 Portfolio in Review

As of Q3 2015, Green Valley Investors held 29 positions worth $4.66B, down 10% from $5.2B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Green Valley Investors's Q3 2015 filing shows 2 new, 3 increased, 2 reduced and 2 closed positions. Its largest new stake was Allergan plc: 400,000 shares worth $109M. The largest sale was Comcast, an estimated $174M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 57% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Green Valley Investors's largest Q3 2015 buy was Allergan plc: 400,000 shares worth $109M.
  • Green Valley Investors added most to Twenty-First Century Fox, Inc. Class A in Q3 2015, an estimated $44.8M increase.
  • Green Valley Investors's biggest Q3 2015 reduction was Sysco, cutting an estimated $47.7M.
  • Green Valley Investors fully exited Comcast in Q3 2015, selling an estimated $174M.
  • Green Valley Investors's ten largest holdings make up 66% of its $4.66B portfolio in Q3 2015.
  • Green Valley Investors opened 2 new positions and closed 2 in Q3 2015.
  • Green Valley Investors's portfolio value fell 10% quarter-over-quarter to $4.66B.

Based on Green Valley Investors's 13F filing for Q3 2015, filed 12 Nov 2015.